Kosmidis, M. L., Pikazis, D., Vlachoyiannopoulos, P., Tzioufas, A. G., & Dalakas, M. C. (2019). Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis. Neurol Neuroimmunol Neuroinflamm.

Kosmidis, Michalis L., Dimitris Pikazis, Panayotis Vlachoyiannopoulos, Athanasios G. Tzioufas, e Marinos C. Dalakas. "Trial of Canakinumab, an IL-1β Receptor Antagonist, in Patients With Inclusion Body Myositis." Neurol Neuroimmunol Neuroinflamm 2019.

Kosmidis, Michalis L., et al. "Trial of Canakinumab, an IL-1β Receptor Antagonist, in Patients With Inclusion Body Myositis." Neurol Neuroimmunol Neuroinflamm 2019.